2 completed, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Fc-EDA: new trials by email Literature Review of Fc-EDA trials Research Report on Fc-EDA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002 EDI200 - X-linked Hypohidrotic Ectodermal Dysplasia | Unknown | Edimer Pharmaceuticals | 10 | 2014-03-01 | 2017-09-05 | |
| Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) EDI200 - X-Linked Hypohidrotic Ectodermal Dysplasia | Phase 2 | Completed | Edimer Pharmaceuticals | 6 | 2013-04-01 | 2016-01-20 |
| A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200 EDI200 - X-linked Hypohidrotic Ectodermal Dysplasia | Phase 1 | Completed | Edimer Pharmaceuticals | 6 | 2012-05-01 | 2013-11-27 |
Ectodermal Dysplasia 1, Anhidrotic (3)
United States (3) · France (2) · Germany (2) · Italy (2) · United Kingdom (2)
Kenneth Huttner, MD, PhD (2) · James Maynard, MD (1) · Ophir Klein, MD, PhD (1)